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Purpose/Objective: The CyberKnife® Robotic Radiosurgery 
System uses two x-ray sources to set up patient, to track 
region of interest and to correct patient's position. The aim 
of this study is to evaluate the number of images per one 
fraction and to calculate the imaging dose for the whole 
treatment for different localizations.  
Materials and Methods: A retrospective analysis was 
performed on a group of 20 patients treated with 
CyberKnife® system. The group included 10 patients with 
brain tumors and 10 patients with prostate cancer. The used 
x-ray parameters were similar within considered localization 
and it was respectively 120 kV, 100 mA and 100 ms for 
prostate and 115 kV, 100 mA and 100 ms for brain. The 
interval between images taken during the fraction was 
specified by physician at the first fraction of the treatment 
and it was 60 s for all patients. Typical amount of beams 
ranged from 148 to 177 for prostate and from 67 to 203 for 
brain. The number of fractions and the fraction dose for each 
localization was respectively: 5 fractions and 7.25 Gy for 
prostate and 3 fractions and 6 Gy for brain. To calculate the 
mean number of images per one fraction the whole 
information about the imaging (such as: number of images 
taken during the positioning, final number of images per 
fraction, image interval and x-ray parameters) for each 
fraction was saved. Based on our results and publications 
data, the surface dose from imaging system, which received 
patients with brain tumors and prostate cancer, was 
calculated.  
Results: The study found that the mean number of acquired 
images per one fraction for each localization was: 77 for 
prostate and 105 for brain. The calculated surface dose was 
18.48 mGy per fraction for prostate case and 10.87 mGy per 
fraction for brain. Total dose from images taken during the 
whole treatment course was 92.4 mGy for prostate cancer 
and 32,61 mGy for brain tumors. 
Conclusions: The number of images and the dose on the 
surface is different for each localization. We suspect, that 
the higher number of images and higher dose from imaging 
system for prostate cancer results from the number of 
fractions and from movements of prostate gland (which 
forced us to make some additional images during the 
positioning and during the time of irradiation) as well. 
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Purpose/Objective: To model interfraction motion variation 
in breast cancer patients with intensity modulated 
radiotherapy (IMRT) based on cone beam CT (CBCT), and to 
quantify interfraction motion in patients with breast cancer. 
Materials and Methods: Eighteen breast cancer patients after 
breast conserving surgery underwent whole breast IMRT were 
included in this study. A total of 452 CBCT scans were 
acquired. Three dimensional interfraction motion and setup 
error before and after on-line CBCT-based corrections were 
quantified. Trends in magnitudes of interfraction motion 
were assessed during treatment. 
Results: Magnitude the interfraction displacements varied 
widely among the 18 patients, and for the same patient, the 
displacement among three dimensional directions were also 
different. The largest interfraction variability in the lateral 
(LR)?anteroposterior (AP) and superoinferior (SI) direction 
were 0.22cm?0.49cm?0.48cm prior to CBCT-based 
corrections, and 0.16cm?0.21cm?0.17cm after on-line CBCT-
based corrections. On-line CBCT-based corrections decreased 
the displacement in SI direction (-0.08 cm vs 0.03 cm, t=-
2.373,P=0.034) and random error (σ), but there were no 
significant differences for systematic error (Σ). No trends in 
interfraction motion were observed before and after on-line 
CBCT-based corrections. 
Conclusions: For breast cancer patients underwent IMRT, 
both interfraction displacement in SI direction and mean 
population random error were reduced after on-line CBCT-
based corrections using automated greyscale match. As a 
result of individual differences,although slight progressive 
changes occur in all directions with the increasing of 
treatment times, no significant trend was identified before 
and after on-line CBCT-based corrections.  
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Purpose/Objective: Regular set up audits facilitate the 
calculation of departmental margins and inform the action 
level and frequency of the IGRT required. They should be 
carried out whenever changes in the patient pathway are 
proposed and become even more important when changing 
from conformal delivery to IMRT with potential reduction in 
margins (1). We present the set up data acquired by using an 
in-house bespoke immobilisation system for our limb sarcoma 
patients. 
Materials and Methods: A retrospective audit was 
undertaken using limb sarcoma patients treated in the period 
2012-2014. Patients who had sarcomas in the thigh region 
were selected as these were the majority of limb cases, using 
the same customised immobilisation. Patients were further 
categorised by gender, laterality, pre- or post-operative 
radiotherapy, and to which joint (knee or hip) was used for 
verification. Aria 11.0 (Varian Medical Systems) was reviewed 
to extract orthogonal kilovoltage (kV) (and megavoltage) 
imaging data taken for each patient for each imaging session. 
Patients were imaged in the first three days of treatment and 
the systematic error was then calculated in longitudinal, 
vertical and lateral directions. The set-up was then adjusted 
for all of the following sessions. An image was additionally 
acquired on session 4 and then weekly to ensure random set 
up error was within tolerance. Population mean, systematic 
and random errors were calculated for measurements in each 
direction. Margins were suggested based on these data (2).  
S912                                                                                                                                         3rd ESTRO Forum 2015 
 
Results: Thirty-four patients were treated in the selected 
time period, 15 male and 19 female, and 13 right limbs and 
21 left limbs. Radiotherapy was delivered pre-operatively in 
18 cases and post-operatively in 16 cases. In 20 cases, 
localisation was performed to the pelvis, 12 cases to the knee 
joint and 2 cases to the shaft of the femur. The mean 
population error in the vertical, longitudinal, and lateral 
directions was 0.3mm, 0.2mm and -0.3 mm respectively. 
Systematic and random errors for these directions were 
calculated to be 1.6(2.4) mm, 1.4(2.2) mm and 1.0(2.5) mm 
respectively. These data resulted in calculated margins in the 
vertical, longitudinal and lateral directions of 5.6mm, 5.1mm 
and 4.3mm respectively. 
Conclusions: These data show that our customised 
immobilisation system and imaging protocol provide a set-up 
reproducibility covered by the margins typically used (5-
7mm). Although margin reduction could be facilitated, there 
are limitations of this audit. Firstly, the limitations of the kV 
imaging length results in only one end of the limb being 
imaged and therefore the effect of rotation cannot be seen 
at the other end. Secondly, since direct visualisation of the 
soft tissue target is not possible with kV imaging, planning 
target volume (PTV) coverage is only assumed. The advent of 
extended length cone beam CT will enable direct 
visualisation of PTV, the entire extent of the femur, and 
other organs at risks e.g. external genitalia. 
   
EP-1665   
Do radiotherapy tattoos reliably guide patient set up for 
breast tumour bed treatment? - A review of current 
practice 
S. Chauhan1, J. Stratford1, I. Patel2, H. Lander3, C. 
Anandadas3, J. Loncaster3 
1The Christie NHS Foundation Trust, Wade Centre for 
Radiotherapy Related Research, Manchester, United Kingdom  
2The Christie NHS Foundation Trust, Christie Medical Physics 
and Engineering, Manchester, United Kingdom  
3The Christie NHS Foundation Trust, Clinical Oncology, 
Manchester, United Kingdom  
 
Purpose/Objective: The introduction of a national trial 
where the whole breast, partial breast and tumour bed are 
concurrently treated using photon radiotherapy and verified 
using daily online Cone Beam CT (CBCT) imaging, has enabled 
this institution to gather 3D set up data in regards to breast 
tumour bed coverage. The tumour bed Clinical Target Volume 
(CTV) is expanded by 0.5cm in 3-dimensions to create the 
tumour bed Planning Target Volume (PTV). Treatment will 
only be delivered when the tumour bed is within 0.2cm of the 
planned position. 
Breast patients were immobilised with both arms above head 
using the Q-Qual™ board. During patient set up, alignment of 
the lateral and anterior radiotherapy tattoos was achieved. 
All planned isocentric shifts were executed to determine the 
L-R, S-I and the initial A-P treatment position. A further A-P 
adjustment may be required dependant on the planned 
concurrent tangential beam entry point in relation to the 
radiotherapy tattoos. This review aims to evaluate the 
reliability of using radiotherapy tattoos for breast patient set 
up in relation to breast tumour bed coverage for trial 
patients at this institution. 
Materials and Methods: Imaging data for trial breast patients 
receiving 3D-CBCT guided radiotherapy, treated between 
January 2014 and October 2014, was retrospectively analysed 
within Elekta Synergy ™–version 4.5.  
The frequency of set-up corrective action greater than 0.2cm 
in response to 3D-CBCT imaging and associated treatment 
margins were determined.  
Results: Data for 135 treatment sessions of 9 patients was 
analysed. 85% of sessions required set-up correction greater 
than 0.2cm in at least one direction; 56% (76/135) of moves 
were required in the L-R direction, 46% (62/135) in the S-I 
direction and 54% (73/135) in the A-P direction (with an 
average magnitude shift of 0.32cm, 0.31cm and 0.34cm 
respectively). 
The required CTV-PTV margin for the tumour bed, based on 
uncorrected and corrected data, is shown in table 1. 
 
 
 
Conclusions: Treatment accuracy within 0.2cm in any 
translational plane will only be achieved in 15% of trial breast 
tumour bed treatments where set up is guided using 
radiotherapy tattoos alone. However, using radiotherapy 
tattoos in conjunction with 3D-CBCT image guidance will 
ensure accurate tumour bed coverage using the current 
0.5cm CTV-PTV expansion of the breast tumour bed. The 
local practice of ensuring tumour bed coverage is within 
0.2cm in any given translational plane prior to treatment 
delivery does imply that a CTV-PTV margin of less than 0.5cm 
could be applied for this trial. However, margin reduction 
should be applied with caution, as delineation and intra-
fractional variation has not been measured.  
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Purpose/Objective: Our center is using NAL3 plus weekly 
imaging as Image Guidance protocols for 3DCRT and IMRT 
techniques. However some of head and neck cancer (HNC) 
patients ended up with daily images. Our goal is to propose a 
method to identify HNC patients that should be included in a 
daily image on-line review protocol after the three first 
fractions. 
Materials and Methods: HNC patients are immobilized by 
customized thermoplastic masks. Patients are first positioned 
by matching lasers to three marks on the mask. Then, kV-MV 
orthogonal images are taken and compared on-line with DRRs 
